SCHEMBL29861932

SCHEMBL29861932

C[Si](C)(C)CCOCn1c(=O)ccc2c(F)c(Br)ccc21

nearest known ligand 0.43

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.43
MAPT P10636 1/20 0.33
DGAT1 O75907 3/20 0.33
PTGER4 P35408 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31129761 0.77 NPC1 (0.38) NPC1DGAT1
SCHEMBL30470561 0.75 NPC1 (0.39) NPC1MAPTDGAT1
SCHEMBL29324119 0.75 NPC1 (0.39) NPC1MAPTDGAT1
SCHEMBL14800179 0.75 NPC1 (0.42) NPC1MAPTDGAT1
SCHEMBL32659805 0.74 NPC1 (0.38) NPC1MAPTDGAT1
SCHEMBL30645867 0.73 NPC1 (0.40) NPC1MAPTDGAT1
SCHEMBL32674400 0.73 NPC1 (0.34) NPC1DGAT1
SCHEMBL31638938 0.72 NPC1 (0.39) NPC1MAPTDGAT1
SCHEMBL637196 0.71 NPC1 (0.42) NPC1MAPTDGAT1
SCHEMBL29081529 0.71 NPC1 (0.40) NPC1MAPTDGAT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4304727-A1 EGFR INHIBITORS Blueprint Medicines Corporation (US) 2024-01-17 EP disclosed
WO-2022192431-A1 EGFR INHIBITORS BLUEPRINT MEDICINES CORPORATION (US) 2022-09-15 WO disclosed